Upcoming event
EAU UROonco: A meeting steered by the EAU Section of Oncological Urology (ESOU)
Back

Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy

  • Duivenvoorden WC,
  • Daneshmand S,
  • Canter D,
  • Lotan Y,
  • Black PC,
  • Abdi H,
  • van Rhijn BW,
  • Fransen van de Putte EE,
  • Zareba P,
  • Koskinen I,
  • Kassouf W,
  • Traboulsi SL,
  • Kukreja JE,
  • Boström PJ,
  • Shayegan B,
  • Pinthus JH

Publication: J Urol., Volume 196, Issue 6, December 2016, Pages 1627-1633

https://www.ncbi.nlm.nih.gov/pubmed/27312316

Piotr Chlosta

The overall incidence of thromboembolic events (TEEs) in patients undergoing neoadjuvant chemotherapy before radical cystectomy was 14%, with 58% of events occurring preoperatively. Prophylaxis to prevent TEEs may need to be initiated earlier in these patients, during the NAC treatment course.